The investment team seeks to invest in companies with franchise characteristics that are benefiting from an accelerating profit cycle and are trading at a discount to private market value.
As of 30 September 2024 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Composite — Gross | 7.78 | 14.13 | 26.24 | 0.10 | 12.71 | — | 13.59 |
Composite — Net | 7.53 | 13.32 | 25.04 | -0.86 | 11.64 | — | 12.51 |
MSCI All Country World Small Mid Index | 9.37 | 12.47 | 25.55 | 3.08 | 9.19 | — | 7.55 |
MSCI All Country World Index | 6.61 | 18.66 | 31.76 | 8.08 | 12.18 | — | 10.40 |
As of 30 September 2024 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Composite — Gross | 7.78 | 14.13 | 26.24 | 0.10 | 12.71 | — | 13.59 |
Composite — Net | 7.53 | 13.32 | 25.04 | -0.86 | 11.64 | — | 12.51 |
MSCI All Country World Small Mid Index | 9.37 | 12.47 | 25.55 | 3.08 | 9.19 | — | 7.55 |
MSCI All Country World Index | 6.61 | 18.66 | 31.76 | 8.08 | 12.18 | — | 10.40 |
Trailing 12 Months Ended 30 September | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Composite — Gross | 39.36 | 30.24 | -32.62 | 17.91 | 26.24 |
Composite — Net | 38.04 | 29.02 | -33.29 | 16.79 | 25.04 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Composite — Gross | 44.29 | 47.94 | 14.01 | -30.08 | 22.24 |
Composite — Net | 42.93 | 46.56 | 12.94 | -30.78 | 21.08 |
MSCI All Country World Small Mid Index | 25.37 | 15.67 | 16.23 | -18.72 | 16.02 |
MSCI All Country World Index | 26.60 | 16.25 | 18.54 | -18.36 | 22.20 |
Top 10 Holdings (% of total portfolio as of 30 September 2024) |
|
---|---|
Argenx SE (Belgium) | 4.1 |
Tyler Technologies Inc (United States) | 4.0 |
London Stock Exchange Group PLC (United Kingdom) | 3.4 |
MACOM Technology Solutions Holdings Inc (United States) | 2.9 |
adidas AG (Germany) | 2.9 |
Techtronic Industries Co Ltd (Hong Kong) | 2.8 |
Ascendis Pharma A/S (Denmark) | 2.8 |
Spotify Technology SA (United States) | 2.3 |
Lattice Semiconductor Corp (United States) | 2.2 |
West Pharmaceutical Services Inc (United States) | 2.1 |
Total | 29.5% |
Portfolio Statistics (as of 30 September 2024) |
|
---|---|
Median Market Cap (Billions) | $15.2 |
Weighted Avg. Market Cap (Billions) | $26.1 |
Weighted Harmonic Avg. P/E (FY1) | 34.6X |
Weighted Harmonic Avg. P/E (FY2) | 29.3X |
Weighted Avg. LT EPS Growth Rate (3-5 Yr) | 21.8% |
Weighted Avg. LT Debt/Capital | 29.8% |
Active Share | 96.8% |
Annual Turnover | 53.0% |
Number of Securities | 63 |
Number of Countries | 13 |
Cash (% of total portfolio) | 6.0% |
Region Allocation
(% of portfolio securities as of 30 September 2024)
Top 10 Countries (% of portfolio securities as of 30 September 2024) |
|
---|---|
United States | 58.6 |
Germany | 9.6 |
United Kingdom | 9.6 |
Belgium | 4.4 |
Denmark | 4.3 |
Hong Kong | 3.0 |
Switzerland | 2.6 |
Sweden | 1.8 |
Singapore | 1.7 |
Canada | 1.4 |
Sector Diversification
(% of portfolio securities as of 30 September 2024)